CRP and Hypertension: Lastly, linear regression analysis with forward variable selection after adjustment for arterial hypertension, active smoking, leukocytes, CRP, troponin I, CK, acetylsalicylic acid (ASA), adenosine diphosphate receptor P2Y12 inhibitors, beta-blockers, and statins indicated that MIF-2 qualifies as a risk factor for CAD (odds ratio [OR]: 0.27; 95% confidence interval [CI]: 0.07-0.47; P = 0.01) (Supplementary Table 4).